Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery
for epithelial ovarian cancer.
All of the women had stage III or IV epithelial ovarian or primary peritoneal cancer, and underwent primary cytoreductive surgery
by a gynecologic oncologist between July 1996 and July 2003.
Evolution of cytoreductive surgery
and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis: are there treatment alternatives?
those undergoing neoadjuvant chemotherapy followed by maximal cytoreductive surgery
According to a review of the English-language literature regarding successful pregnancy after cytoreductive surgery
in infertile women with adenomyosis, on average one out of every eight women experienced uterine rupture.
Some surgeons are hesitant to pursue cytoreductive surgery
in these kinds of patients as aggressively as they might in patients with fewer surgical risk factors because of previous data showing poorer survival rates in older women.
Currently, cytoreductive surgery
combined with perioperative intraperitoneal chemotherapy is the standard treatment for patients with peritoneal spread of primary appendiceal tumors.
Therefore, the aim of the present study is to evaluate the influence of HRT on the prognosis of the enrolled patients and investigate the feasibility of HRT for premenopausal women with SOC after cytoreductive surgery
Meta-analysis of surgery in advanced ovarian carcinoma: is maximum cytoreductive surgery
an independent determinant of prognosis Am J Obstet Gynecol 1992 ; 166: 504-11.
Furthermore, there is emerging evidence that cytoreductive surgery
, the removal of as much of the tumour as possible, may enhance the response to systemic therapy in RCC patients.
Stage IVB endometrial carcinoma: the role of cytoreductive surgery
and determinants of survival.
Optimal cytoreductive surgery
is beneficial for patients with stage III and stage IV disease.